Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.61 |
| ▸ | RAB9A | P51151 | 5/20 | 0.57 |
| ▸ | NPC1 | O15118 | 5/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.53 |
| ▸ | APP | P05067 | 3/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | LDHA | P00338 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29875298 | 1.00 | SMN1; SMN2 (0.61) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPT | |
| SCHEMBL2174373 | 0.88 | RAB9A (0.50) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPT | |
| SCHEMBL202298 | 0.84 | SMN1; SMN2 (0.57) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPT | |
| SCHEMBL30181739 | 0.84 | SMN1; SMN2 (0.57) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPT | |
| SCHEMBL2098849 | 0.81 | RAB9A (0.56) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPT | |
| Iodomethane SCHEMBL27623269 | 0.81 | SMN1; SMN2 (0.53) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPT | |
| SCHEMBL84327 | 0.79 | SMN1; SMN2 (0.66) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPT | |
| SCHEMBL30542465 | 0.79 | SMN1; SMN2 (0.66) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPT | |
| SCHEMBL1849649 | 0.76 | RAB9A (0.51) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPT | |
| SCHEMBL141868 | 0.76 | RAB9A (0.51) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118355041-A | Method for underwater bonding | 汉高股份有限及两合公司 | 2024-07-16 | — | — | CN | claimed |
| CN-113045993-A | Polishing solution for processing ultra-smooth low-damage bearing steel surface and application thereof | 西南交通大学 | 2021-06-29 | — | — | CN | claimed |
| EP-3464446-B1 | TWO-PART CYANOACRYLATE CURABLE ADHESIVE SYSTEM | Henkel IP & Holding GmbH (DE) | 2021-06-23 | — | — | EP | claimed |
| CN-109476874-B | Two-part cyanoacrylate curable adhesive systems | 汉高知识产权控股有限责任公司 | 2021-04-16 | — | — | CN | claimed |
| CN-111116573-A | Near-infrared fluorescent probe for simultaneously detecting DNA and RNA under dual channels and preparation method and application thereof | 中山大学 | 2020-05-08 | — | — | CN | claimed |
| EP-3464446-A1 | TWO-PART CYANOACRYLATE CURABLE ADHESIVE SYSTEM | Henkel IP & Holding GmbH (DE) | 2019-04-10 | — | — | EP | claimed |
| US-10100235-B2 | Two-part cyanoacrylate curable adhesive system | Henkel IP & Holding GmbH (DE) | 2018-10-16 | — | — | US | claimed |
| WO-2017202698-A1 | TWO-PART CYANOACRYLATE CURABLE ADHESIVE SYSTEM | Henkel IP & Holding GmbH (DE) | 2017-11-30 | — | — | WO | claimed |
| US-20170335151-A1 | TWO-PART CYANOACRYLATE CURABLE ADHESIVE SYSTEM | HENKEL AG & CO. KGAA (DE) | 2017-11-23 | — | — | US | claimed |
| US-20260125346-A1 | Isoquinolinone Derivatives and 4H-Quinolizinone Derivatives and Pharmaceutical Compositions Thereof for the Treatment of Disease | BEONE MEDICINES I GMBH (CH) | 2026-05-07 | — | — | US | disclosed |
| EP-4721737-A1 | USE OF PHARMACEUTICAL COMPOSITION COMPRISING COMPOUND HAVING BIS(AZANYLYLIDENE) SULFONYL STRUCTURE FOR TREATING ANEMIA-RELATED DISEASES | Scinnohub Pharmaceutical Co., Ltd. (CN) | 2026-04-08 | — | — | EP | disclosed |
| EP-4709725-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | Progentos Therapeutics, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| EP-4685143-A1 | DOUBLE REGULATOR FOR MGLUR5 AND HDAC6 AND USE THEREOF | Vivozon,Inc. (KR) | 2026-01-28 | — | — | EP | disclosed |
| US-20250346597-A1 | CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES | BEONE MEDICINES I GMBH (CH) | 2025-11-13 | — | — | US | disclosed |
| US-20040180941-A1 | 3-(1-[3-(1,3-Benzothiazol-6-yl)propylcarbamoyl]cycloalkyl)propanoic acid derivatives as NEP inhibitors | PFIZER INC | 2004-09-16 | — | — | US | disclosed |
| US-20040132046-A1 | Synthesis and evaluation of new cyanine dyes as minor groove of [POLY (dA-dT)]2 binders | LIGHT UP TECHNOLOGIES AB (SE) | 2004-07-08 | — | — | US | disclosed |
| US-20040116399-A1 | Inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. | 2004-06-17 | — | — | US | disclosed |
| US-20040116399-A1 | Inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. | 2004-06-17 | — | — | US | disclosed |
| EP-1390433-A1 | SYNTHESIS AND EVALUATION OF NEW CYANINE DYES AS MINOR GROOVE OF POLY(DA-DT)] 2 BINDERS | Light Up Technologies AB (SE) | 2004-02-25 | — | — | EP | disclosed |
| WO-2002090443-A1 | SYNTHESIS AND EVALUATION OF NEW CYANINE DYES AS MINOR GROOVE OF [POLY(DA-DT)]2 BINDERS | LIGHT UP TECHNOLOGIES AB (SE) | 2002-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040180941-A1 | 3-(1-[3-(1,3-Benzothiazol-6-yl)propylcarbamoyl]cycloalkyl)propanoic acid derivatives as NEP inhibitors | MME, PREP, DNPEP | SMN1; SMN2 3498/4885RAB9A 3193/4885NPC1 1004/4885 |
| US-20250346597-A1 | CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES | DGKG, DGKA, DGKK | SMN1; SMN2 4584/4885RAB9A 1548/4885NPC1 1908/4885 |
| US-20260125346-A1 | Isoquinolinone Derivatives and 4H-Quinolizinone Derivatives and Pharmaceutical Compositions Thereof for the Treatment of Disease | NR3C1, NR3C2, PIK3R4 | SMN1; SMN2 1452/4885RAB9A 260/4885NPC1 151/4885 |
| US-20040132046-A1 | Synthesis and evaluation of new cyanine dyes as minor groove of [POLY (dA-dT)]2 binders | DRD4, FUT4, DRD1 | SMN1; SMN2 4549/4885RAB9A 3345/4885NPC1 3194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.